Mark Your Calendar: SpaceX Could Be a Very Different Stock After June 12

SpaceX is reportedly targeting a June 12 IPO at $135 per share, implying a $1.77 trillion valuation and up to $75 billion in new capital raised. The article highlights Morningstar's caution that the company may be overvalued, with a more reasonable estimate near $780 billion, and advises investors may get a better entry point after the listing. The piece is primarily a valuation and timing warning rather than a business update.

Analysis

The immediate market overhang is not SpaceX itself but the pricing of private-to-public AI optionality across the late-stage venture complex. A debut at a premium multiple would likely reset marks for frontier AI/private assets higher, but if the listing is met with weak aftermarket demand, the first-order loser is the credibility of “AI-as-a-TAM” underwriting, which can compress multiples for adjacent pre-IPO names and for public AI infrastructure winners trading on duration rather than cash flow.

The sharpest second-order beneficiary may be the exchange ecosystem and the bankers able to capture follow-on flow, while the sharpest loser is consensus momentum positioning in speculative AI growth. Morningstar’s skepticism creates a useful signal: if the market anchors to a post-IPO dislocation, the cleanest risk/reward is likely not chasing the deal but waiting for the first 2-6 week de-rating window when lockup/secondary concerns and revenue reality collide.

For NVDA and INTC, the article is mildly supportive only insofar as it keeps the AI narrative hot, but it also raises a subtle risk: if capital rotates into a headline IPO, some incremental demand may come out of the existing AI basket. NVDA is insulated by earnings power; INTC is more reflexive and could trade as a sympathy beneficiary if investors view the IPO as validation of AI capex, though that effect should fade quickly if the IPO does not hold gains.

The contrarian read is that the market may be underestimating how little near-term public-market appetite there is for mega-cap private tech at venture-style valuation discipline. If the stock pops on debut, the better trade is usually to fade the enthusiasm into strength rather than wait for an arbitrary calendar date; if it fails to price well, that would be a broader warning that late-stage private AI multiples need another reset.

Key Decisions for Investors

• Do not chase the IPO on day one; wait 2-6 weeks for post-listing volatility and potential secondary supply. Best risk/reward likely comes after the first dislocation, not at the offering.
• If we want exposure to the AI theme, keep NVDA as the preferred liquid proxy and avoid adding on IPO hype. Any rotation from public AI leaders into the debut should be faded if NVDA underperforms the semis basket by >2% on the week.
• Use INTC as a tactical sympathy trade only if the IPO is interpreted as validation for AI capex. Express via a short-dated call spread rather than stock; asymmetric upside if sentiment ripples through, limited loss if the effect fades.
• Consider a pairs trade: long NDAQ / short a basket of high-multiple private-AI proxies if the debut heats up. The exchange gets direct monetization from IPO activity while speculative AI valuations take on event risk.
• If the IPO prices at a wide premium to reasonable fundamentals and trades poorly in the first week, initiate a small tactical short via puts or a collar in the aftermarket. Target a 10-20% pullback over 1-2 months as enthusiasm normalizes.